“Scientists and clinicians in the early phases of their career are crucial to our mission to end cancer and play a central role in driving innovation in all areas of cancer research, prevention, diagnosis and treatment,” said Giulio Draetta, M.D., Ph.D., chief scientific officer at MD Anderson. “We congratulate these junior investigators on receiving such notable recognition from AACR for their high-impact work.” Navin: Outstanding Achievement in Basic Cancer Research This prestigious AACR scientific achievement award was established to recognize an early career investigator for achievements in basic cancer research. Navin was selected for his seminal contributions to the understanding of genome evolution and intratumor heterogeneity in breast cancer and for his invention of single-cell DNA sequencing, which has impacted many diverse fields of biology and biomedicine and has directly contributed to the establishment of the single cell genomics field.